GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Getein Biotech Inc (SHSE:603387) » Definitions » 5-Year Yield-on-Cost %

Getein Biotech (SHSE:603387) 5-Year Yield-on-Cost % : 15.12 (As of May. 27, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Getein Biotech 5-Year Yield-on-Cost %?

Getein Biotech's yield on cost for the quarter that ended in Mar. 2024 was 15.12.


The historical rank and industry rank for Getein Biotech's 5-Year Yield-on-Cost % or its related term are showing as below:

SHSE:603387' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 1.83   Med: 4.33   Max: 16.47
Current: 15.12


During the past 12 years, Getein Biotech's highest Yield on Cost was 16.47. The lowest was 1.83. And the median was 4.33.


SHSE:603387's 5-Year Yield-on-Cost % is ranked better than
93.85% of 309 companies
in the Medical Devices & Instruments industry
Industry Median: 2.19 vs SHSE:603387: 15.12

Competitive Comparison of Getein Biotech's 5-Year Yield-on-Cost %

For the Medical Devices subindustry, Getein Biotech's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Getein Biotech's 5-Year Yield-on-Cost % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Getein Biotech's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Getein Biotech's 5-Year Yield-on-Cost % falls into.



Getein Biotech 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Getein Biotech is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Getein Biotech  (SHSE:603387) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Getein Biotech 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Getein Biotech's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Getein Biotech (SHSE:603387) Business Description

Traded in Other Exchanges
N/A
Address
No. 9 Bofu Road, Luhe District, Nanjing, CHN, 211505
Getein Biotech Inc is an in-vitro diagnostic company. It is specializing in analytical medical devices and point-of-care testing kits. Its product lines consist of cardiovascular, inflammatory, diabetes, fertility, renal, liver and specialty assays.
Executives
Su En Kui Director
Yan Bin Director
Kong Ting Ting Director
Xu Xing De Director
Su En Ben Director

Getein Biotech (SHSE:603387) Headlines

No Headlines